期刊文献+

自身免疫性肝炎-原发性胆汁性胆管炎重叠综合征的临床及病理学特征分析 被引量:12

Clinical and pathological features of autoimmune hepatitis-primary biliary cholangitis overlap syndrome versus autoimmune hepatitis
下载PDF
导出
摘要 目的自身免疫性肝炎-原发性胆汁性胆管炎重叠综合征(AIH-PBC OS)的诊断仍然是目前尚未解决的难点,对AIH-PBC OS与AIH的临床与病理特征进行比较分析,以加强对AIH-PBC OS的认识,提高AIH-PBC OS的早期诊断率。方法前瞻性收集2015年1月20日-2016年11月28日于四川大学华西医院就诊且经肝穿刺确诊的AIH-PBC OS患者(50例)和单纯AIH患者(57例)的临床特征、生化免疫学指标、自身抗体和肝组织病理学表现等方面,比较AIH-PBC OS与AIH的不同特点。实验室指标等计量资料2组间比较采用非参数秩和检验;临床特征、肝组织病理学表现等计数资料2组间比较采用χ~2检验。结果AIH-PBC OS组发病年龄低于AIH组(Z=-1.975,P=0.048),男女性别比无明显差异。AIH-PBC OS患者较AIH患者更易出现瘙痒症状(22.0%vs 7.0%,χ~2=4.960,P=0.026)。AIH-PBC OS组ALP、GGT和IgM水平以及AMA的阳性率均高于AIH组(Z=-6.250、-4.789、-5.407、χ~2=26.811,P值均<0.001),而血清ALT、AST和IgG的水平则低于AIH组(Z=-2.916、-3.381、-2.285,P=0.004、0.001、0.022)。肝穿刺活组织检查AIH-PBC OS组患者胆管损伤、胆管缺失、肉芽肿样病变和胆汁淤积的发生率均高于AIH组(χ~2=25.612、15.953、6.490、10.042,P<0.001、<0.001、0.001、0.002)。结论 AIH-PBC OS虽然同时具备AIH和PBC的特点,但并非AIH与PBC的简单叠加。瘙痒,ALP、GGT、IgM水平显著升高,AMA阳性,病理学表现出的炎症性胆管病变和胆汁淤积均对AIH-PBC OS的诊断有提示作用。由于AIH-PBC OS的肝脏炎症损伤程度和自身免疫异常程度总体可能较AIH轻,故在AIH-PBC OS诊断时应考虑适当放宽巴黎标准中ALT、IgG的水平,以防因漏诊而影响治疗方案的选择和患者预后。 Objective To investigate the clinical and pathological features of autoimmune hepatitis(AIH)-primary biliary cholangitis(PBC) overlap syndrome(AIH-PBC OS) versus AIH,since it is still difficult to diagnose AIH-PBC OS in clinical practice,and to enhance the knowledge of AIH-PBC OS and improve its early diagnostic rate.Methods A prospective study was performed for the clinical data,biochemical and immunological markers,autoantibody,and liver pathology of 50 patients with AIH-PBC OS confirmed by liver biopsy who visited West China Hospital,Sichuan University,from January 20,2015 to November 28,2016 and 57 patients with AIH alone,in order to compare the features of AIH-PBC OS and AIH.Continuous data such as laboratory markers were expressed as median M(inter-quartile range) and the nonparametric rank sum test was used for comparison of these data between two groups;categorical data including clinical features、histopathological manifestations were expressed as rates and the chi-square test was used for comparison of these data between two groups.Results The AIH-PBC OS group had a significantly lower age of onset than the AIH group(Z=-1.975,P=0.048),while there was no significant difference in male/female sex ratio between the two groups.The AIH-PBC OS group had a significantly higher proportion of patients with pruritus than the AIH group(22.0% vs 7.0%,χ^2=4.960,P=0.026).Compared with the AIH group,the AIH-PBC OS group had significantly higher levels of alkaline phosphatase(ALP),gamma-glutamyl transpeptidase(GGT),and immunoglobulin M(IgM)(Z=-6.250,-4.789,and-5.407,all P〈0.001),a significantly higher positive rate of antimitochondrial antibody(AMA)(χ^2=26.811,P〈0.001),and significantly lower serum levels of alanine aminotransferase(ALT),aspartate aminotransferase,and immunoglobulin G(IgG)(Z=-2.916,-3.381,and-2.285,P=0.004,0.001,and 0.022).The AIH-PBC OS group had significantly higher incidence rates of bile duct injury,bile duct loss,granulomatous disease,and cholestasis than the AIH group(χ-2=25.612,15.953,6.490,and 10.042,P〈0.001,0.001,0.001,and 0.002).Conclusion Although AIH-PBC OS has the features of both AIH and PBC,it is not a simple overlap between AIH and PBC.Pruritus,significant increases in the levels of ALP,GGT,and IgM,positive AMA,and inflammatory bile duct disease and cholestasis may have implications for the diagnos of AIH-PBC OS.Since AIH-PBC OS may have milder liver inflammatory injury and autoimmune abnormalities than AIH,the levels of ALT and IgG in Paris criteria can be broadened during the diagnosis of AIH-PBC OS,in order to prevent missed diagnosis and avoid affecting the selection of treatment regimen and patients' prognosis.
作者 王婷婷 鲁昌立 凡小丽 杨丽 WANG Tingting;LU Changli;FAN Xiaoli;et al.(Department of Gastroenterology, West China Hospital, Sichuan University, Chengdu 610041, China)
出处 《临床肝胆病杂志》 CAS 2017年第11期2179-2185,共7页 Journal of Clinical Hepatology
基金 四川省科技厅支撑计划(2016FZ0062)
关键词 肝炎 自身免疫性 胆管炎 硬化性 病理学 临床 疾病特征 hepatitis, autoimmune cholangitis, sclerosing pathology, clinical disease attributes
  • 相关文献

参考文献3

二级参考文献73

  • 1BEUERS U, GERSHWIN ME, GISH RG, et al. Changing no- menclature for PBC. From ' cirrhosis' to ' cholangitis' I- J ]. Gut, 2015, 64(11), 1671 -1672.
  • 2CHUANG N, GROSS RG, ODIN JA. Update on the epidemi- ology of primary biliary cirrhosis [ J ]. Expert Rev Gastroen- terol Hepatol, 2011, 5(5), 583-590.
  • 3JIANG XH, ZHONG RQ, FAN XY, et al. Characterization of M2 antibodies in asymptomatic Chinese population [ J ]. World J Gastroenterol, 2003, 9(91 : 2128 -2131 .
  • 4LIU H, LIU Y, WANG L, et al. Prevalence of primary biliary cir- rhosis in adults referring hospital for annual health check -up in Southern China[J]. BMC Gastroenterol, 2010, 10, 100.
  • 5MAYO MJ. Natural history of primary biliary cirrhosis[J]. Clin Uver Dis, 2008, 12(2) : 277 -288.
  • 6PRINCE M, CHETWYND A, NEWMAN W, et al. Survival and sympotom progression in geogapfically based cohort of patients with primay biliay cirrhosis, follow up for up to 28 years [ J ]. Gastroenterology, 2002, 123 (4) = 1044 - 1051.
  • 7IMAM MH, LINDOR KD. The natural histoy of primay biliay cirrhosis[J]. Semin Liver Dis, 2014, 34(3) ~ 329 -333.
  • 8PAR~:S A, CABALLERiA L, RODI~S J. Excellent long -term survival in patients with primary biliary cirrhosis and biochemi- cal response to ursodeoxycholic acid [ J ]. Gastroenterology, 2006, 130(3) : 715 -720.
  • 9CORPECHOT C, CHAZOUILLC:RES O, POUPON R, et al. Bio- chemical response to ursodeoxycholic acid and long -term prognosis in primary biliary cirrhosis~J~. Hepatology, 2008, 48 (3) : 871 -877.
  • 10RUDIC JS, POROPAT G, KRSTIC MN, et al. Ursodeoxycholic acid for primary biliary cirrhosis [ J ]. Cochrane Database Syst Rev, 2012, 12 ~ CD000551.

共引文献265

同被引文献45

引证文献12

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部